MCG as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction (MICRO)
Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction
Sponsor: Genetesis Inc.
Listed as NCT05150054, this observational or N/A phase trial focuses on Coronary Microvascular Dysfunction and Ischemic Non-Obstructive Coronary Artery Disease and remains completed. Sponsored by Genetesis Inc., it has been updated 7 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2023 — Jul 2024 [monthly]
Completed
Status: Enrolling By Invitation → Completed
-
Jul 2023 — Sep 2023 [monthly]
Enrolling By Invitation
-
Mar 2023 — Jul 2023 [monthly]
Enrolling By Invitation
▶ Show 2 earlier versions
-
Apr 2022 — Mar 2023 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jan 2022 — Apr 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Genetesis Inc.
For direct contact, visit the study record on ClinicalTrials.gov .